Metagenomi, Inc. Pre-Tax Profit Margin 2022-2024 | MGX

Metagenomi, Inc. pre-tax profit margin from 2022 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

Metagenomi, Inc. Pre-Tax Profit Margin 2022-2024 | MGX

Metagenomi, Inc. pre-tax profit margin from 2022 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Related Stocks
Company NameMarket
Cap
Zoetis Inc. (ZTS)$79.5B
Takeda Pharmaceutical Co. (TAK)$43.4B
Merck KGaA (MKKGY)$21B
Astellas Pharma Inc. (ALPMY)$20.3B
Sandoz Group AG Sponsored ADR (SDZNY)$19.9B
United Therapeutics Corporation (UTHR)$17.9B
Summit Therapeutics PLC (SMMT)$16.1B
Neurocrine Biosciences, Inc. (NBIX)$12.9B
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY)$12.3B
Catalent, Inc. (CTLT)$10.8B
Jazz Pharmaceuticals PLC (JAZZ)$7.7B
Madrigal Pharmaceuticals, Inc. (MDGL)$7.4B
Orion OYJ Unsponsored ADR (ORINY)$6.8B
Corcept Therapeutics Incorporated (CORT)$6.2B
Ionis Pharmaceuticals, Inc. (IONS)$6.1B
Crinetics Pharmaceuticals, Inc. (CRNX)$4.8B
PTC Therapeutics, Inc. (PTCT)$3.5B
AMNEAL PHARMACEUTICALS, INC. (AMRX)$2.8B
Dyne Therapeutics, Inc. (DYN)$2.8B
Catalyst Pharmaceuticals, Inc. (CPRX)$2.8B
Arrowhead Pharmaceuticals, Inc. (ARWR)$2.7B
Soleno Therapeutics, Inc. (SLNO)$2.6B
NewAmsterdam Pharma Company N.V. (NAMS)$2.2B
Recursion Pharmaceuticals, Inc. (RXRX)$2.2B
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA)$1.9B
Harrow, Inc. (HROW)$1.8B
Evotec AG (EVO)$1.7B
Ocular Therapeutix, Inc. (OCUL)$1.7B
BioCryst Pharmaceuticals, Inc. (BCRX)$1.7B
ARS Pharmaceuticals, Inc. (SPRY)$1.7B